Medicines for heart failure

Medicines (by active ingredient)

AmlodipineCoronary Artery Disease Chronic Stable Angina Vasospastic Angina (Prinzmetal's or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction. AtorvastatinAdults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in. LisinoprilAdults and pediatric patients 6 years of age and older Adjunct therapy for heart failure Treatment of Acute Myocardial Infarction 1.1 Hypertension Lisinopril tablet USP is indicated for the treatment of hypertension in. SpironolactoneSpironolactone tablets are an aldosterone antagonist indicated for: The treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure. FurosemideAdults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. RamiprilRamipril capsules USP are indicated in stable patients who have demonstrated clinical signs of congestive heart failure post-myocardial infarction. EmpagliflozinJARDIANCE is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in. ValsartanLowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults Post-myocardial infarction , for the reduction of cardiovascu… HydrochlorothiazideHydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. EplerenoneAdult patients with symptomatic heart failure with reduced ejection fraction (HFrEF) after an acute myocardial infarction. TorsemideTorsemide is a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. IndapamideIndapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. EnalaprilTreatment of symptomatic heart failure. Sodium NitroprussideSodium nitroprusside is also indicated for the treatment of acute congestive heart failure. ThiamineIt is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. Milrinone LactateMilrinone Lactate Injection, USP is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. MetolazoneEdema accompanying congestive heart failure. IvabradineIvabradine is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in. BumetanideBumetanide tablets, USP are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. ChlorthalidoneChlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. AmilorideAmiloride HCl is indicated as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension to: a. Candesartan· Treatment of heart failure (NYHA class II-IV). ChlortalidoneChlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Lisinopril DihydrateAdults and pediatric patients 6 years of age and older Adjunct therapy for heart failure Treatment of Acute Myocardial Infarction 1.1 Hypertension Lisinopril tablet USP is indicated for the treatment of hypertension in. SacubitrilENTRESTO is a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in. Sacubitril and ValsartanLowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults Post-myocardial infarction , for the reduction of cardiovascu… Thiamine NitrateIt is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure.

Brands

CarvedilolCarvedilol tablets are an alpha/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure left ventricular dysfunction following myocardial infarction in clinically stable patients hypertension 1.1 Heart Failure Carvedilol tablets are ind… AcetazolamideFor adjunctive treatment of: edema due to congestive heart failure. DigoxinDigoxin is a cardiac glycoside indicated for: Treatment of mild to moderate heart failure in adults. DapagliflozinTo reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in.